<DOC>
	<DOCNO>NCT01076569</DOCNO>
	<brief_summary>This pilot research trial study biomarkers bone marrow sample pediatric patient high risk acute myeloid leukemia . Studying sample bone marrow patient cancer laboratory may help doctor identify learn biomarkers related cancer .</brief_summary>
	<brief_title>Biomarkers Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To provide detailed , molecular map pediatric high risk acute myeloid leukemia ( AML ) . II . To identify mutation , expression profile , gene copy number , loss heterozygosity ( LOH ) status genomic methylation pattern order identify novel change associate pediatric AML . III . To generate fibroblast cell line order obtain germline nucleic acid marrow specimens AML patient induction failure . IV . To identify genomic alteration contribute induction failure childhood AML . OUTLINE : Banked bone marrow sample diagnosis remission use develop detailed molecular map pediatric high-risk acute myeloid leukemia . Analysis include genome single nucleotide polymorphism ( SNP ) genotyping , expression , methylation profiling .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Leukemia , Monocytic , Acute</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Acute</mesh_term>
	<mesh_term>Hypereosinophilic Syndrome</mesh_term>
	<mesh_term>Leukemia , Erythroblastic , Acute</mesh_term>
	<mesh_term>Leukemia , Eosinophilic , Acute</mesh_term>
	<mesh_term>Leukemia , Basophilic , Acute</mesh_term>
	<mesh_term>Leukemia , Megakaryoblastic , Acute</mesh_term>
	<criteria>Diagnosis acute myeloid leukemia Highrisk disease Treated COGAAML03P1 COGAAML0531 Meets follow criterion : Initial remission know adverse risk factor High quantity quality ribonucleic acid ( RNA ) deoxyribonucleic acid ( DNA ) available Highly enrich specimen &gt; = 50 % blast available</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>